Compounds > nsc 330770

Page last updated: 2024-08-23

nsc 330770 and Leukemia L 1210

nsc 330770 has been researched along with Leukemia L 1210 in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (57.14)	18.7374
1990's	3 (42.86)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Comber, RN; Rener, GA; Temple, C; Waud, WR	1
Rener, GA; Temple, C	2
Temple, C	1
Comber, RN; Rener, GA; Temple, C	1
Comber, RN; Elliott, RD; Montgomery, JA; Rose, JD; Temple, C; Wheeler, GP	1
Comber, RN; Elliott, RD; Kussner, CL; Montgomery, JA; Rose, JD; Temple, C; Wheeler, GP	1

Other Studies

7 other study(ies) available for nsc 330770 and Leukemia L 1210

Article	Year
Antimitotic agents. Alterations at the 2,3-positions of ethyl (5-amino-1,2-dihydropyrido[3,4-b]pyrazin-7-yl)carbamates. Journal of medicinal chemistry, 1991, Volume: 34, Issue:11 Topics: Animals; Antineoplastic Agents; Carbamates; Leukemia L1210; Leukemia P388; Mice; Pyrazines; Structure-Activity Relationship	1991
Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates. Journal of medicinal chemistry, 1990, Volume: 33, Issue:11 Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Leukemia L1210; Molecular Structure; Pyrazines; Pyridines; Structure-Activity Relationship; Triazines	1990
Antimitotic agents: synthesis of imidazo[4,5-c]pyridin-6-ylcarbamates and imidazo[4,5-b]pyridin-5-ylcarbamates. Journal of medicinal chemistry, 1990, Volume: 33, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Division; Chemical Phenomena; Chemistry; Leukemia L1210; Mice; Tumor Cells, Cultured	1990
New anticancer agents: chiral isomers of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazine-7-car bamate . Journal of medicinal chemistry, 1989, Volume: 32, Issue:9 Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Colchicine; Drug Synergism; Isomerism; Leukemia L1210; Leukemia P388; Mice; Pyrazines; Structure-Activity Relationship; Tubulin; Vincristine	1989
New anticancer agents: alterations of the carbamate group of ethyl (5-amino-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl)car bamates. Journal of medicinal chemistry, 1989, Volume: 32, Issue:10 Topics: Animals; Antineoplastic Agents; Carbamates; Cell Survival; Indicators and Reagents; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Pyridazines; Structure-Activity Relationship; Tumor Cells, Cultured	1989
1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships. Journal of medicinal chemistry, 1983, Volume: 26, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Leukemia L1210; Mice; Mitosis; Pyrazines; Pyridines; Structure-Activity Relationship	1983
New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines). Journal of medicinal chemistry, 1982, Volume: 25, Issue:9 Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Folic Acid Antagonists; Leukemia L1210; Leukemia P388; Mice; Mitosis; Pyrazines; Pyridines	1982